Products
| Lapatinib ditosylate | |
| Product name | Lapatinib ditosylate |
| Chinese name | N-(3-氯-4-((3-氟苯基)甲氧基)苯基)-6-(5-(((2-(甲磺酰基)乙基)氨基)甲基)-2-呋喃基)-4-喹唑啉胺二对甲苯磺酸盐；二对甲苯磺酸拉帕替尼；拉帕替尼二甲苯磺酰酸盐；拉帕替尼二甲磺酸盐；二甲苯磺酸拉帕替尼(盐)；对甲苯磺酸拉帕替尼；对二甲苯磺酸拉帕替尼盐；二甲苯磺酸拉帕替尼(一水)；拉帕替尼对甲苯磺酸盐；拉帕替尼二对甲苯磺酸盐一水合物 |
| English name | Lapatinib ditosylate |
| Molecular formula | C41H40ClFN4O11S3 |
| Molecular weight | 925.46 |
| CAS No. | 388082-78-8 |
| Product photo |  |
| Structure |  |
| chemical properties | |
| Appearance | |
| Melting point | |
| Content | >98.0% |
| Moisture | |
| Packing | 1kg，5kg，25kg |
The other explanation |
Uses: used for joint card overexpression of capecitabine in the treatment of, who previously received including anthracyclines, paclitaxel, trastuzumab (Herceptin) in the treatment of advanced or metastatic breast cancer. |
